Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab

M Polat, S Yüksel, NÜ Şahin - Human Vaccines & …, 2018 - Taylor & Francis
To the Editors, We read the article by Dretler et al. 1 regarding meningococcal disease and
vaccination with great interest. As stated in this review, individuals receiving the complement …

Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome

AR Levy, P Chen, K Johnston, Y Wang… - Journal of Medical …, 2022 - Taylor & Francis
Aims This study compared the aggregate duration of treatment administration of approved
eculizumab and ravulizumab treatment regimens and resultant productivity implications for …

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab

G Andries, M Karass, S Yandrapalli, K Linder… - … Hematology & Oncology, 2017 - Springer
Background Atypical hemolytic uremic syndrome is a rare disorder which is known to cause
acute thrombotic microangiopathy during pregnancy with poor maternal and fetal outcomes …

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

L Facchini, M Lucchesi, A Stival, RM Roperto… - Journal of Medical Case …, 2017 - Springer
Background The incidence of gemcitabine-induced hemolytic uremic syndrome has already
been described in adults. Several approaches have been employed in the treatment of …

Renal biopsy prognostic findings in children with atypical hemolytic uremic syndrome

S Yüksel, İ Işık Gönül, N Canpolat… - Pediatric and …, 2020 - journals.sagepub.com
Background The aim of this study was to investigate the histopathological findings in kidney
biopsies in children with atypical hemolytic uremic syndrome (aHUS) and to determine …

Eculizumab-Associated Moraxella lacunata Bacteremia and Systemic Inflammatory Response Syndrome in a Toddler with Atypical Hemolytic Uremic Syndrome

PS Bicoll, A Goyal, NB Blatt… - Clinical Medicine Insights …, 2021 - journals.sagepub.com
Moraxella lacunata, a low-virulence Gram-negative coccobacillus, is classically associated
with conjunctivitis and upper respiratory tract infections; systemic infections such as sepsis …

Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies

BA Andrien Jr, DL Sheridan, PP Tamburini… - US Patent …, 2019 - Google Patents
2017-09-20 Assigned to ALEXION PHARMACEUTICALS, INC. reassignment ALEXION
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

Anti-C5 antibodies having improved pharmacokinetics

BA Andrien Jr, DL Sheridan, PP Tamburini… - US Patent …, 2017 - Google Patents
The disclosure provides antibodies that are useful for, among other things, inhibiting
terminal complement (eg, the assembly and/or activity of the C5b-9 TCC) and C5a …

Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies

BA Andrien Jr, DL Sheridan, PP Tamburini… - US Patent …, 2020 - Google Patents
Related US Application Data Continuation of application No. 15/708,658, filed on Sep. 19,
2017, now Pat. No. 10,227,400, which is a continuation of application No. 15/492,622, filed …

Complement factor B mutation-associated aHUS and myocardial infarction

N Noronha, FD Costa, A Dias, A Dinis - Case Reports, 2017 - casereports.bmj.com
A 6-month-old female infant was referred with a 3-day history of low-grade fever, slight nasal
congestion and rhinorrhoea. On admission, the clinical findings were unremarkable and she …